Polaris of San Diego to Build $50 Million Facility in Chengdu

by Richard Daverman, PhD

February 28, 2013 -- Polaris Group, a San Diego biotech with multinational collaborations, will build a $50 million drug manufacturing facility in Chengdu, the capital of Sichuan Province in Southwest China. Polaris is currently conducting a global Phase III trial of a biotech drug for hepatocellular cancer. Previously, Polaris intended to build the facility in Taiwan, which is the source of the company’s startup capital. But Taiwanese land restriction policies proved too difficult, and Polaris decided to locate the facility in Chengdu instead. More details....

Back to news